Ann E. Jerse - Publications

Affiliations: 
Uniformed Services University of the Health Sciences, Bethesda, MD 
Area:
Microbiology Biology

85 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Waltmann A, Balthazar JT, Begum AA, Hua N, Jerse AE, Shafer WM, Hobbs MM, Duncan JA. MtrCDE Efflux Pump During Experimental Genital Tract Infection in Men and Mice Reveals the Presence of Within-Host Colonization Bottleneck. Medrxiv : the Preprint Server For Health Sciences. PMID 37425726 DOI: 10.1101/2023.06.23.23291824  0.384
2022 Holley CL, Dhulipala V, Balthazar JT, Le Van A, Begum AA, Chen SC, Read TD, Matoga M, Hoffman IF, Golparian D, Unemo M, Jerse AE, Shafer WM. A Single Amino Acid Substitution in Elongation Factor G Can Confer Low-Level Gentamicin Resistance in . Antimicrobial Agents and Chemotherapy. 66: e0025122. PMID 35465683 DOI: 10.1128/aac.00251-22  0.315
2021 Turner JM, Connolly KL, Aberman KE, Fonseca JC, Singh A, Jerse AE, Nicholas RA, Davies C. Molecular Features of Cephalosporins Important for Activity against Antimicrobial-Resistant . Acs Infectious Diseases. PMID 33533239 DOI: 10.1021/acsinfecdis.0c00400  0.31
2020 Matthias KA, Reveille A, Connolly KL, Jerse AE, Gao YS, Bash MC. Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains. Vaccine. 38: 2396-2405. PMID 32037226 DOI: 10.1016/J.Vaccine.2020.01.038  0.387
2019 Garges E, Early J, Waggoner S, Rahman N, Golden D, Agan B, Jerse A. Biomedical Response to Neisseria gonorrhoeae and Other Sexually Transmitted Infections in the US Military. Military Medicine. 184: 51-58. PMID 31778198 DOI: 10.1093/Milmed/Usy431  0.322
2019 Russell MW, Jerse AE, Gray-Owen SD. Progress Toward a Gonococcal Vaccine: The Way Forward. Frontiers in Immunology. 10: 2417. PMID 31681305 DOI: 10.3389/Fimmu.2019.02417  0.398
2019 Chen S, Connolly KL, Rouquette-Loughlin C, D'Andrea A, Jerse AE, Shafer WM. Could Dampening Expression of the Neisseria gonorrhoeae -Encoded Efflux Pump Be a Strategy To Preserve Currently or Resurrect Formerly Used Antibiotics To Treat Gonorrhea? Mbio. 10. PMID 31409679 DOI: 10.1128/Mbio.01576-19  0.444
2019 Kim WJ, Higashi D, Goytia M, Rendón MA, Pilligua-Lucas M, Bronnimann M, McLean JA, Duncan J, Trees D, Jerse AE, So M. Commensal Neisseria Kill Neisseria gonorrhoeae through a DNA-Dependent Mechanism. Cell Host & Microbe. PMID 31378677 DOI: 10.1016/J.Chom.2019.07.003  0.312
2019 Raterman EL, Jerse AE. Female Mouse Model of Neisseria gonorrhoeae Infection. Methods in Molecular Biology (Clifton, N.J.). 1997: 413-429. PMID 31119637 DOI: 10.1007/978-1-4939-9496-0_24  0.471
2019 Baarda BI, Zielke RA, Le Van A, Jerse AE, Sikora AE. Neisseria gonorrhoeae MlaA influences gonococcal virulence and membrane vesicle production. Plos Pathogens. 15: e1007385. PMID 30845186 DOI: 10.1371/Journal.Ppat.1007385  0.396
2019 Connolly KL, Eakin AE, Gomez C, Osborn BL, Unemo M, Jerse AE. Pharmacokinetic Data Are Predictive of Efficacy for Cefixime and Ceftriaxone against Susceptible and Resistant Strains in the Gonorrhea Mouse Model. Antimicrobial Agents and Chemotherapy. PMID 30642924 DOI: 10.1128/Aac.01644-18  0.349
2019 Connolly K, Soileau L, Jerse A. P690 Establishment of the gonorrhea mouse model for pre-clinical testing of antibiotics that follow the PK driver fauc/MIC Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.756  0.419
2019 Van AL, Rahman N, Dozier N, Gann PM, Regeimbal J, Mccoy A, Soge O, Garges E, Jerse A. P645 Peruvian gonococcal strains reveal novel NG-MAST types and false-positive β-lactamase isolates with blatem gene mutations Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.713  0.364
2019 Early J, Van AL, Dozier N, Waggoner S, Garges E, Jerse A. P039 A central reference laboratory for antimicrobial resistant neisseria gonorrhoeae in the us department of defense Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.246  0.34
2019 Matthias K, Connolly K, Begum A, Jerse A, Macintyre A, Sempowski G, Gao Y, Bash M. O01.6 Meningococcal vesicle vaccines deleted for major outer membrane proteins enhance gonococcal clearance in a murine model Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.109  0.42
2018 Baarda BI, Zielke RA, Jerse AE, Sikora AE. Lipid-Modified Azurin of Is Not Surface Exposed and Does Not Interact With the Nitrite Reductase AniA. Frontiers in Microbiology. 9: 2915. PMID 30538694 DOI: 10.3389/Fmicb.2018.02915  0.325
2018 Zielke RA, Le Van A, Baarda BI, Herrera MF, Acosta CJ, Jerse AE, Sikora AE. SliC is a surface-displayed lipoprotein that is required for the anti-lysozyme strategy during Neisseria gonorrhoeae infection. Plos Pathogens. 14: e1007081. PMID 29975784 DOI: 10.1371/Journal.Ppat.1007081  0.467
2018 Rouquette-Loughlin CE, Dhulipala V, Reimche JL, Raterman E, Begum AA, Jerse AE, Shafer WM. - and -acting factors influence expression of the -encoded efflux pump of and levels of gonococcal susceptibility to substrate antimicrobials. Antimicrobial Agents and Chemotherapy. PMID 29891604 DOI: 10.1128/Aac.00821-18  0.332
2018 Washington MA, Jerse AE, Rahman N, Pilligua-Lucas M, Garges EC, Latif NH, Akhvlediani T. First description of a cefixime- and ciprofloxacin-resistant isolate with mutations in key antimicrobial susceptibility-determining genes from the country of Georgia. New Microbes and New Infections. 24: 47-51. PMID 29872530 DOI: 10.1016/J.Nmni.2018.04.004  0.361
2018 Vincent LR, Jerse AE. Biological feasibility and importance of a gonorrhea vaccine for global public health. Vaccine. PMID 29680200 DOI: 10.1016/J.Vaccine.2018.02.081  0.33
2018 Vincent LR, Kerr SR, Tan Y, Tomberg J, Raterman EL, Dunning Hotopp JC, Unemo M, Nicholas RA, Jerse AE. -Selected Compensatory Mutations Restore the Fitness Cost of MosaicAlleles That Confer Ceftriaxone Resistance in. Mbio. 9. PMID 29615507 DOI: 10.1128/Mbio.01905-17  0.421
2018 Butler MM, Waidyarachchi SL, Connolly KL, Jerse AE, Chai W, Lee RE, Kohlhoff SA, Shinabarger DL, Bowlin TL. Aminomethyl spectinomycins as therapeutics for drug-resistant gonorrhea and chlamydial co-infections. Antimicrobial Agents and Chemotherapy. PMID 29483122 DOI: 10.1128/Aac.00325-18  0.405
2018 Cern A, Connolly KL, Jerse AE, Barenholz Y. In vitro susceptibility of Neisseria gonorrhoeae strains to mupirocin. An antibiotic reformulated to parenteral nano-liposomal antibiotic. Antimicrobial Agents and Chemotherapy. PMID 29339382 DOI: 10.1128/Aac.02377-17  0.378
2017 Rice PA, Shafer WM, Ram S, Jerse AE. Neisseria gonorrhoeae: Drug Resistance, Mouse Models, and Vaccine Development. Annual Review of Microbiology. 71: 665-686. PMID 28886683 DOI: 10.1146/Annurev-Micro-090816-093530  0.465
2017 Wang L, Xing D, Le Van A, Jerse AE, Wang S. Structure-based design of ferritin nanoparticle immunogens displaying antigenic loops of Neisseria gonorrhoeae. Febs Open Bio. 7: 1196-1207. PMID 28781959 DOI: 10.1002/2211-5463.12267  0.328
2017 Gangaiah D, Raterman E, Wu H, Fortney KR, Gao H, Liu Y, Jerse AE, Spinola SM. Both MisR (CpxR) and MisS (CpxA) are Required for Neisseria gonorrhoeae Infection in a Murine Model of Lower Genital Tract Infection. Infection and Immunity. PMID 28652307 DOI: 10.1128/Iai.00307-17  0.449
2017 Rouquette-Loughlin CE, Zalucki YM, Dhulipala VL, Balthazar JT, Doyle RG, Nicholas RA, Begum AA, Raterman EL, Jerse AE, Shafer WM. Control of gdhR Expression in Neisseria gonorrhoeae via Autoregulation and a Master Repressor (MtrR) of a Drug Efflux Pump Operon. Mbio. 8. PMID 28400529 DOI: 10.1128/Mbio.00449-17  0.415
2017 Liu Y, Hammer LA, Liu W, Hobbs MM, Zielke RA, Sikora AE, Jerse AE, Egilmez NK, Russell MW. Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model. Mucosal Immunology. PMID 28272393 DOI: 10.1038/Mi.2017.11  0.395
2017 Tomberg J, Fedarovich A, Vincent LR, Jerse AE, Unemo M, Davies C, Nicholas RA. Alanine-501 Mutations in Penicillin-Binding Protein 2 from Neisseria gonorrhoeae: Structure, Mechanism, and Effects on Cephalosporin Resistance and Biological Fitness. Biochemistry. PMID 28145684 DOI: 10.1021/Acs.Biochem.6B01030  0.332
2017 Rahman N, Kluz N, Puplampu-Attram N, Letizia A, Montano S, Regeimbal J, Mccoy A, Akhvlediani T, Washington M, Soge O, Macalino G, Jerse A. P3.164 Antibiotic resistance and molecular typing of neisseria gonorrhoeae isolated from the three overseas sites through the global emerging infections surveillance and response system (GEIS) Sexually Transmitted Infections. 93. DOI: 10.1136/Sextrans-2017-053264.399  0.384
2016 Schmitt DM, Connolly KL, Jerse AE, Detrick MS, Horzempa J. Antibacterial activity of resazurin-based compounds against Neisseria gonorrhoeae in vitro and in vivo. International Journal of Antimicrobial Agents. PMID 27451856 DOI: 10.1016/J.Ijantimicag.2016.06.009  0.427
2016 Wetzler LM, Feavers IM, Gray-Owen SD, Jerse AE, Rice PA, Deal CD. Summary and recommendations from a National Institute of Allergy and Infectious Diseases (NIAID) workshop on "Gonorrhea Vaccines: the Way Forward". Clinical and Vaccine Immunology : Cvi. PMID 27335384 DOI: 10.1128/Cvi.00230-16  0.343
2016 Zielke RA, Wierzbicki IH, Baarda BI, Gafken PR, Soge OO, Holmes KK, Jerse AE, Unemo M, Sikora AE. Proteomics-driven antigen discovery for development of vaccines against gonorrhea. Molecular & Cellular Proteomics : McP. PMID 27141096 DOI: 10.1074/Mcp.M116.058800  0.337
2015 Yedery RD, Jerse AE. Augmentation of Cationic Antimicrobial Peptide Production with Histone Deacetylase Inhibitors as a Novel Epigenetic Therapy for Bacterial Infections. Antibiotics (Basel, Switzerland). 4: 44-61. PMID 27025614 DOI: 10.3390/Antibiotics4010044  0.364
2015 Ohneck EA, Goytia M, Rouquette-Loughlin CE, Joseph SJ, Read TD, Jerse AE, Shafer WM. Overproduction of the MtrCDE efflux pump in Neisseria gonorrhoeae produces unexpected changes in cellular transcription patterns. Antimicrobial Agents and Chemotherapy. 59: 724-6. PMID 25367915 DOI: 10.1128/Aac.04148-14  0.329
2015 Connolly K, Hiltke T, Gomez C, Unemo M, Jerse A. 009.2 Establishment of the gonorrhoea mouse model for pre-clinical testing of antimicrobial agents againstneisseria gonorrhoeae Sexually Transmitted Infections. 91: A45.1-A45. DOI: 10.1136/Sextrans-2015-052270.128  0.41
2015 Leduc I, Jerse A. 006.3 Host-directed therapeutics as adjunctive therapy for antibiotic-resistantneisseria gonorrhoeae Sexually Transmitted Infections. 91: A38.1-A38. DOI: 10.1136/Sextrans-2015-052270.111  0.407
2014 Kandler JL, Joseph SJ, Balthazar JT, Dhulipala V, Read TD, Jerse AE, Shafer WM. Phase-variable expression of lptA modulates the resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides. Antimicrobial Agents and Chemotherapy. 58: 4230-3. PMID 24820072 DOI: 10.1128/Aac.03108-14  0.379
2014 Packiam M, Yedery RD, Begum AA, Carlson RW, Ganguly J, Sempowski GD, Ventevogel MS, Shafer WM, Jerse AE. Phosphoethanolamine decoration of Neisseria gonorrhoeae lipid A plays a dual immunostimulatory and protective role during experimental genital tract infection. Infection and Immunity. 82: 2170-9. PMID 24686069 DOI: 10.1128/Iai.01504-14  0.465
2014 Jerse AE, Bash MC, Russell MW. Vaccines against gonorrhea: current status and future challenges. Vaccine. 32: 1579-87. PMID 24016806 DOI: 10.1016/J.Vaccine.2013.08.067  0.386
2013 Hobbs MM, Anderson JE, Balthazar JT, Kandler JL, Carlson RW, Ganguly J, Begum AA, Duncan JA, Lin JT, Sparling PF, Jerse AE, Shafer WM. Lipid A's structure mediates Neisseria gonorrhoeae fitness during experimental infection of mice and men. Mbio. 4: e00892-13. PMID 24255126 DOI: 10.1128/Mbio.00892-13  0.446
2013 Jerse AE, Deal CD. Vaccine research for gonococcal infections: where are we? Sexually Transmitted Infections. 89: iv63-8. PMID 24243883 DOI: 10.1136/Sextrans-2013-051225  0.385
2013 Vincent LR, Unemo M, Duncan M, Nicholas RA, Jerse AE. O21.3 Fitness Studies onNeisseria GonorrhoeaeHarboring MosaicpenAAlleles from Ceftriaxone-Resistant Isolates Predict the Spread of Resistance to Extended-Spectrum Cephalosporins Sexually Transmitted Infections. 89: A67.2-A67. DOI: 10.1136/Sextrans-2013-051184.0205  0.43
2012 Vonck Stankowski R, Cole JG, Jerse AE. The natural history of incident gonococcal infection in adolescent women: similar observations in a female mouse model of gonococcal and chlamydial coinfection. Sexually Transmitted Diseases. 39: 238. PMID 22337114 DOI: 10.1097/Olq.0B013E3182471974  0.307
2012 Packiam M, Wu H, Veit SJ, Mavrogiorgos N, Jerse AE, Ingalls RR. Protective role of Toll-like receptor 4 in experimental gonococcal infection of female mice Mucosal Immunology. 5: 19-29. PMID 21937985 DOI: 10.1038/Mi.2011.38  0.412
2011 Ohneck EA, Zalucki YM, Johnson PJ, Dhulipala V, Golparian D, Unemo M, Jerse AE, Shafer WM. A novel mechanism of high-level, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeae. Mbio. 2. PMID 21933917 DOI: 10.1128/Mbio.00187-11  0.4
2011 Jerse AE, Wu H, Packiam M, Vonck RA, Begum AA, Garvin LE. Estradiol-Treated Female Mice as Surrogate Hosts for Neisseria gonorrhoeae Genital Tract Infections. Frontiers in Microbiology. 2: 107. PMID 21747807 DOI: 10.3389/Fmicb.2011.00107  0.489
2011 Hobbs MM, Sparling PF, Cohen MS, Shafer WM, Deal CD, Jerse AE. Experimental Gonococcal Infection in Male Volunteers: Cumulative Experience with Neisseria gonorrhoeae Strains FA1090 and MS11mkC. Frontiers in Microbiology. 2: 123. PMID 21734909 DOI: 10.3389/Fmicb.2011.00123  0.454
2011 Zhu W, Chen CJ, Thomas CE, Anderson JE, Jerse AE, Sparling PF. Vaccines for gonorrhea: can we rise to the challenge? Frontiers in Microbiology. 2: 124. PMID 21687431 DOI: 10.3389/Fmicb.2011.00124  0.369
2011 Vonck RA, Darville T, O'Connell CM, Jerse AE. Chlamydial infection increases gonococcal colonization in a novel murine coinfection model. Infection and Immunity. 79: 1566-77. PMID 21245268 DOI: 10.1128/Iai.01155-10  0.457
2011 Jerse A, Vonck R, Darville T. O4-S2.01 The host response to chlamydial infection results in increased gonococcal colonisation in a novel coinfection model Sexually Transmitted Infections. 87: A85-A86. DOI: 10.1136/Sextrans-2011-050109.145  0.458
2010 Feinen B, Jerse AE, Gaffen SL, Russell MW. Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection Mucosal Immunology. 3: 312-321. PMID 20107432 DOI: 10.1038/Mi.2009.139  0.325
2010 Cole JG, Fulcher NB, Jerse AE. Opacity proteins increase Neisseria gonorrhoeae fitness in the female genital tract due to a factor under ovarian control. Infection and Immunity. 78: 1629-41. PMID 20100859 DOI: 10.1128/Iai.00996-09  0.5
2010 Packiam M, Veit SJ, Anderson DJ, Ingalls RR, Jerse AE. Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses. Infection and Immunity. 78: 433-40. PMID 19901062 DOI: 10.1128/Iai.00711-09  0.448
2009 Cole JG, Jerse AE. Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops. Plos One. 4: e8108. PMID 19956622 DOI: 10.1371/Journal.Pone.0008108  0.324
2009 Muench DF, Kuch DJ, Wu H, Begum AA, Veit SJ, Pelletier ME, Soler-García AA, Jerse AE. Hydrogen peroxide-producing lactobacilli inhibit gonococci in vitro but not during experimental genital tract infection. The Journal of Infectious Diseases. 199: 1369-78. PMID 19301977 DOI: 10.1086/597390  0.423
2009 Wu H, Soler-García AA, Jerse AE. A strain-specific catalase mutation and mutation of the metal-binding transporter gene mntC attenuate Neisseria gonorrhoeae in vivo but not by increasing susceptibility to oxidative killing by phagocytes. Infection and Immunity. 77: 1091-102. PMID 19114548 DOI: 10.1128/Iai.00825-08  0.439
2008 Song W, Condron S, Mocca BT, Veit SJ, Hill D, Abbas A, Jerse AE. Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17beta-estradiol-treated mice. Vaccine. 26: 5741-51. PMID 18762223 DOI: 10.1016/J.Vaccine.2008.08.020  0.434
2008 Warner DM, Shafer WM, Jerse AE. Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Molecular Microbiology. 70: 462-78. PMID 18761689 DOI: 10.1111/J.1365-2958.2008.06424.X  0.387
2008 Garvin LE, Bash MC, Keys C, Warner DM, Ram S, Shafer WM, Jerse AE. Phenotypic and genotypic analyses of Neisseria gonorrhoeae isolates that express frequently recovered PorB PIA variable region types suggest that certain P1a porin sequences confer a selective advantage for urogenital tract infection. Infection and Immunity. 76: 3700-9. PMID 18541655 DOI: 10.1128/Iai.00265-08  0.421
2007 Warner DM, Folster JP, Shafer WM, Jerse AE. Regulation of the MtrC-MtrD-MtrE efflux-pump system modulates the in vivo fitness of Neisseria gonorrhoeae. The Journal of Infectious Diseases. 196: 1804-12. PMID 18190261 DOI: 10.1086/522964  0.432
2007 Serino L, Nesta B, Leuzzi R, Fontana MR, Monaci E, Mocca BT, Cartocci E, Masignani V, Jerse AE, Rappuoli R, Pizza M. Identification of a new OmpA-like protein in Neisseria gonorrhoeae involved in the binding to human epithelial cells and in vivo colonization. Molecular Microbiology. 64: 1391-403. PMID 17542928 DOI: 10.1111/J.1365-2958.2007.05745.X  0.442
2007 Soler-García AA, Jerse AE. Neisseria gonorrhoeae catalase is not required for experimental genital tract infection despite the induction of a localized neutrophil response. Infection and Immunity. 75: 2225-33. PMID 17296753 DOI: 10.1128/Iai.01513-06  0.479
2007 Exley RM, Wu H, Shaw J, Schneider MC, Smith H, Jerse AE, Tang CM. Lactate acquisition promotes successful colonization of the murine genital tract by Neisseria gonorrhoeae. Infection and Immunity. 75: 1318-24. PMID 17158905 DOI: 10.1128/Iai.01530-06  0.417
2006 Wu H, Jerse AE. Alpha-2,3-sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection. Infection and Immunity. 74: 4094-103. PMID 16790783 DOI: 10.1128/Iai.00433-06  0.476
2006 Simms AN, Jerse AE. In vivo selection for Neisseria gonorrhoeae opacity protein expression in the absence of human carcinoembryonic antigen cell adhesion molecules. Infection and Immunity. 74: 2965-74. PMID 16622235 DOI: 10.1128/Iai.74.5.2965-2974.2006  0.725
2005 Ngampasutadol J, Ram S, Blom AM, Jarva H, Jerse AE, Lien E, Goguen J, Gulati S, Rice PA. Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection. Proceedings of the National Academy of Sciences of the United States of America. 102: 17142-7. PMID 16275906 DOI: 10.1073/Pnas.0506471102  0.448
2004 Soler-García AA, Jerse AE. A Neisseria gonorrhoeae catalase mutant is more sensitive to hydrogen peroxide and paraquat, an inducer of toxic oxygen radicals. Microbial Pathogenesis. 37: 55-63. PMID 15312845 DOI: 10.1016/J.Micpath.2004.04.007  0.398
2004 Spencer SE, Valentin-Bon IE, Whaley K, Jerse AE. Inhibition of Neisseria gonorrhoeae Genital Tract Infection by Leading-Candidate Topical Microbicides in a Mouse Model Journal of Infectious Diseases. 189: 410-419. PMID 14745698 DOI: 10.1086/381125  0.387
2003 Jerse AE, Sharma ND, Simms AN, Crow ET, Snyder LA, Shafer WM. A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection. Infection and Immunity. 71: 5576-82. PMID 14500476 DOI: 10.1128/Iai.71.10.5576-5582.2003  0.731
2002 Jerse AE, Crow ET, Bordner AN, Rahman I, Cornelissen CN, Moench TR, Mehrazar K. Growth of Neisseria gonorrhoeae in the female mouse genital tract does not require the gonococcal transferrin or hemoglobin receptors and may be enhanced by commensal lactobacilli. Infection and Immunity. 70: 2549-58. PMID 11953395 DOI: 10.1128/Iai.70.5.2549-2558.2002  0.377
2001 Zeitlin L, Hoen TE, Achilles SL, Hegarty TA, Jerse AE, Kreider JW, Olmsted SS, Whaley KJ, Cone RA, Moench TR. Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models. Sexually Transmitted Diseases. 28: 417-23. PMID 11460027 DOI: 10.1097/00007435-200107000-00010  0.328
2000 Plante M, Jerse A, Hamel J, Couture F, Rioux CR, Brodeur BR, Martin D. Intranasal immunization with gonococcal outer membrane preparations reduces the duration of vaginal colonization of mice by Neisseria gonorrhoeae. The Journal of Infectious Diseases. 182: 848-55. PMID 10950780 DOI: 10.1086/315801  0.398
1999 Jerse AE. Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice Infection and Immunity. 67: 5699-5708. PMID 10531218 DOI: 10.1128/Iai.67.11.5699-5708.1999  0.493
1995 Jarvis KG, Girón JA, Jerse AE, Mcdaniel TK, Donnenberg MS, Kaper JB. Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation Proceedings of the National Academy of Sciences of the United States of America. 92: 7996-8000. PMID 7644527 DOI: 10.1073/Pnas.92.17.7996  0.667
1995 Raimondi F, Jerse AE, Boedeker EC, Kaper JB, Guandalini S, Rubino A, Fasano A. 68 RET IS A NOVEL ENTEROTOXIN PRODUCED BY RABBIT SPECIFIC EPEC STRAIN RDEC-1 Journal of Pediatric Gastroenterology and Nutrition. 20: 462. DOI: 10.1097/00005176-199505000-00078  0.572
1994 Cohen MS, Cannon JG, Jerse AE, Charniga LM, Isbey SF, Whicker LG. Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development. The Journal of Infectious Diseases. 169: 532-7. PMID 8158024 DOI: 10.1093/Infdis/169.3.532  0.388
1994 Jerse AE, Cohen MS, Drown PM, Whicker LG, Isbey SF, Seifert HS, Cannon JG. Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. The Journal of Experimental Medicine. 179: 911-20. PMID 8113683 DOI: 10.1084/Jem.179.3.911  0.405
1994 Seifert HS, Wright CJ, Jerse AE, Cohen MS, Cannon JG. Multiple gonococcal pilin antigenic variants are produced during experimental human infections. The Journal of Clinical Investigation. 93: 2744-9. PMID 7911129 DOI: 10.1172/Jci117290  0.419
1992 Barrett TJ, Kaper JB, Jerse AE, Kaye Wachsmuth I. Virulence factors in shiga-like toxin-producing escherichia coli isolated from humans and cattle Journal of Infectious Diseases. 166: 979-980. PMID 1569356 DOI: 10.1093/infdis/165.5.979  0.502
1991 Jerse AE, Gicquelais KG, Kaper JB. Plasmid and chromosomal elements involved in the pathogenesis of attaching and effacing Escherichia coli Infection and Immunity. 59: 3869-3875. PMID 1937746  0.506
1991 Jerse AE, Kaper JB. The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid Infection and Immunity. 59: 4302-4309. PMID 1682258  0.516
1991 Francis CL, Jerse AE, Kaper JB, Falkow S. Characterization of interactions of enteropathogenic Escherichia coli O127:H6 with mammalian cells in vitro. The Journal of Infectious Diseases. 164: 693-703. PMID 1680136 DOI: 10.1093/Infdis/164.4.693  0.656
1990 Jerse AE, Yu J, Tall BD, Kaper JB. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells Proceedings of the National Academy of Sciences of the United States of America. 87: 7839-7843. PMID 2172966 DOI: 10.1073/Pnas.87.20.7839  0.472
1990 Jerse AE, Martin WC, Galen JE, Kaper JB. Oligonucleotide probe for detection of the enteropathogenic Escherichia coli (EPEC) adherence factor of localized adherent EPEC Journal of Clinical Microbiology. 28: 2842-2844. PMID 1980682  0.658
Show low-probability matches.